{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T21:23:49Z","timestamp":1776201829018,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,3,24]],"date-time":"2011-03-24T00:00:00Z","timestamp":1300924800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s00105-010-2119-0","type":"journal-article","created":{"date-parts":[[2011,3,23]],"date-time":"2011-03-23T10:24:08Z","timestamp":1300875848000},"page":"297-307","source":"Crossref","is-referenced-by-count":12,"title":["Seborrhoisches Ekzem","Seborrheic Dermatitis"],"prefix":"10.1007","volume":"62","author":[{"given":"R.","family":"Aschoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Kempter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Meurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,24]]},"reference":[{"key":"2119_CR1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1468-3083.2004.00693.x","volume":"18","author":"Gupta","year":"2004","unstructured":"Gupta AK, Bluhm R (2004) Seborrheic dermatitis. J Eur Acad Dermatol Venereol 18(1):13\u201326","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2119_CR2","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1468-3083.2006.01923.x","volume":"21","author":"Moraes","year":"2007","unstructured":"Moraes AP de, Arruda EA de, Vitoriano MA et al (2007) An open-label efficacy pilot study with pimecrolimus cream 1% in adults with facial seborrhoeic dermatitis infected with HIV. J Eur Acad Dermatol Venereol 21(5):596\u2013601","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2119_CR3","first-page":"321494","volume":"2010","author":"Luca","year":"2010","unstructured":"Luca C de, Valacchi G (2010) Surface lipids as multifunctional mediators of skin responses to environmental stimuli. Mediators Inflamm 2010:321494 [Epub 2010 Oct 20]","journal-title":"Mediators Inflamm"},{"key":"2119_CR4","unstructured":"Plewig G, Jansen T (2007) Seborrheic dermatitis. In: Wolff K, Goldsmith LA, Katz AI et al (Hrsg) Fitzpatrick\u2019s dermatology in general medicine, 7. Aufl. McGraw-Hill Professional, New York, NY, S 219\u2013225"},{"key":"2119_CR5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1001\/archderm.139.3.318","volume":"139","author":"Foley","year":"2003","unstructured":"Foley P, Zuo Y, Plunkett A et al (2003) The frequency of common skin conditions in preschool-aged children in Australia: seborrheic dermatitis and pityriasis capitis (cradle cap). Arch Dermatol 139(3):318\u2013322","journal-title":"Arch Dermatol"},{"key":"2119_CR6","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2004-1616","volume":"115","author":"Williams","year":"2005","unstructured":"Williams JV, Eichenfield LF, Burke BL et al (2005) Prevalence of scalp scaling in prepubertal children. Pediatrics 115(1):e1\u2013e6","journal-title":"Pediatrics"},{"key":"2119_CR7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5021\/ad.2010.22.2.149","volume":"22","author":"Oh","year":"2010","unstructured":"Oh BH, Lee YW, Choe YB, Ahn KJ (2010) Epidemiologic study of malassezia yeasts in seborrheic dermatitis patients by the analysis of 26S rDNA PCR-RFLP. Ann Dermatol 22(2):149\u2013155","journal-title":"Ann Dermatol"},{"key":"2119_CR8","first-page":"344","volume":"53","author":"Prohic","year":"2010","unstructured":"Prohic A (2010) Distribution of malassezia species in seborrhoeic dermatitis: correlation with patients\u2018 cellular immune status. Mycoses 53(4):344\u2013349","journal-title":"Mycoses"},{"key":"2119_CR9","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1087-0024.2005.10104.x","volume":"10","author":"Ro","year":"2005","unstructured":"Ro BI, Dawson TL (2005) The role of sebaceous gland activity and scalp microfloral metabolism in the etiology of seborrheic dermatitis and dandruff. J Investig Dermatol Symp Proc 10(3):194\u2013197","journal-title":"J Investig Dermatol Symp Proc"},{"key":"2119_CR10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00105-009-1894-y","volume":"61","author":"Zouboulis","year":"2010","unstructured":"Zouboulis CC (2010) Die Talgdr\u00fcse. Hautarzt 61(6):467\u2013477","journal-title":"Hautarzt"},{"key":"2119_CR11","first-page":"14","volume":"2","author":"Kim","year":"2009","unstructured":"Kim GK (2009) Seborrheic dermatitis and malassezia species: How are they related? J Clin Aesthet Dermatol 2(11):14\u201317","journal-title":"J Clin Aesthet Dermatol"},{"key":"2119_CR12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3928\/00904481-20090521-01","volume":"38","author":"Poindexter","year":"2009","unstructured":"Poindexter GB, Burkhart CN, Morrell DS (2009) Therapies for pediatric seborrheic dermatitis. Pediatr Ann 38(6):333\u2013338","journal-title":"Pediatr Ann"},{"key":"2119_CR13","first-page":"125","volume":"8","author":"Bikowski","year":"2009","unstructured":"Bikowski J (2009) Facial seborrheic dermatitis: a report on current status and therapeutic horizons. J Drugs Dermatol 8(2):125\u2013133","journal-title":"J Drugs Dermatol"},{"key":"2119_CR14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1468-3083.2006.01927.x","volume":"21","author":"Seckin","year":"2007","unstructured":"Seckin D, Gurbuz O, Akin O (2007) Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study. J Eur Acad Dermatol Venereol 21(3):345\u2013350","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2119_CR15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/16537150601092944","volume":"18","author":"Ratnavel","year":"2007","unstructured":"Ratnavel RC, Squire RA, Boorman GC (2007) Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis. J Dermatol Treat 18(2):88\u201396","journal-title":"J Dermatol Treat"},{"key":"2119_CR16","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1046\/j.1365-2133.2001.04144.x","volume":"144","author":"Scaparro","year":"2001","unstructured":"Scaparro E, Quadri G, Virno G et al (2001) Evaluation of the efficacy and tolerability of oral terbinafine (Daskil\u00ae) in patients with seborrheic dermatitis. a multicentre, randomized, investigator-blinded, placebo-controlled trial. Br J Dermatol 144(4):854\u2013857","journal-title":"Br J Dermatol"},{"key":"2119_CR17","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1159\/000066452","volume":"15","author":"Pi\u00e9rard-Franchimont","year":"2002","unstructured":"Pi\u00e9rard-Franchimont C, Goffin V, Decroix J, Pi\u00e9rard GE (2002) A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis. Skin Pharmacol Appl Skin Physiol 15(6):434\u2013441","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"key":"2119_CR18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3109\/09546630802687349","volume":"20","author":"Cicek","year":"2009","unstructured":"Cicek D, Kandi B, Bakar S, Turgut D (2009) Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrhoeic dermatitis: a randomized clinical study. J Dermatolog Treat 20(6):344\u2013349","journal-title":"J Dermatolog Treat"},{"key":"2119_CR19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/09546630802286993","volume":"20","author":"Koc","year":"2009","unstructured":"Koc E, Arca E, Kose O, Akar A (2009) An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis. J Dermatolog Treat 20(1):4\u20139","journal-title":"J Dermatolog Treat"},{"key":"2119_CR20","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1525-1470.1998.1998015406.x","volume":"15","author":"Brodell","year":"1998","unstructured":"Brodell RT, Patel S, Venglarcik JS et al (1998) The safety of ketoconazole shampoo for infantile seborrheic dermatitis. Pediatr Dermatol 15(5):406\u2013407","journal-title":"Pediatr Dermatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-010-2119-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-010-2119-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-010-2119-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T10:49:05Z","timestamp":1712314145000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-010-2119-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,24]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["2119"],"URL":"https:\/\/doi.org\/10.1007\/s00105-010-2119-0","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,24]]}}}